Skip to main content

Advertisement

SpringerLink
Log in

Minimally invasive interval debulking surgery after neoadjuvant chemotherapy for metastatic ovarian cancer: a national study in the United States

  • Correspondence
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gueli Alletti S, Bottoni C, Fanfani F, Gallotta V, Chiantera V, Costantini B, Cosentino F, Ercoli A, Scambia G, Fagotti A (2016) Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study. Am J Obstet Gynecol 214:503.e1–503.e6

    Article  Google Scholar 

  2. Gueli Alletti S, Petrillo M, Vizzielli G, Bottoni C, Nardelli F, Costantini B, Quagliozzi L, Gallotta V, Scambia G, Fagotti A (2016) Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: a single-institution retrospective case-control study. Gynecol Oncol 143:516–520

    Article  CAS  Google Scholar 

  3. Brown J, Drury L, Crane EK, Anderson WE, Tait DL, Higgins RV, Naumann RW (2019) When less is more: minimally invasive surgery compared with laparotomy for interval debulking after neoadjuvant chemotherapy in women with advanced ovarian cancer. J Minim Invasive Gynecol 26:902–909

    Article  Google Scholar 

  4. Fagotti A, Alletti SG, Corrado G, Cola E, Vizza E, Vieira M, Andrade CE, Tsunoda A, Favero G, Zapardiel I, Pasciuto T, Scambia G (2019) The INTERNATIONAL MISSION study: minimally invasive surgery in ovarian neoplasms after neoadjuvant chemotherapy. Int J Gynecol Cancer 29:5–9

    Article  CAS  Google Scholar 

  5. Melamed A, Nitecki R, Boruta DM 2nd, Del Carmen MG, Clark RM, Growdon WB, Goodman A, Schorge JO, Rauh-Hain JA (2017) Laparoscopy compared with laparotomy for debulking ovarian cancer after neoadjuvant chemotherapy. Obstet Gynecol 129:861–869

    Article  Google Scholar 

Download references

Funding

Ensign Endowment for Gynecologic Cancer Research (K.M.)

Author information

Authors and Affiliations

  1. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, 2020 Zonal Avenue IRD520, Los Angeles, CA, 90033, USA

    Koji Matsuo, Rachel S. Mandelbaum, Shinya Matsuzaki & Lynda D. Roman

  2. Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA

    Koji Matsuo & Lynda D. Roman

  3. Department of Obstetrics and Gynecology, University of Freiburg, Freiburg, Germany

    Maximilian Klar

  4. Division of Acute Care Surgery, Department of Surgery, University of Southern California, Los Angeles, CA, USA

    Kazuhide Matsushima

  5. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA

    Jason D. Wright

Authors
  1. Koji Matsuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maximilian Klar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rachel S. Mandelbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shinya Matsuzaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kazuhide Matsushima
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lynda D. Roman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jason D. Wright
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

KM: conceptualization, funding acquisition, investigation, methodology, analysis, project administration, supervision, validation, writing (original draft). RSM: data acquisition and analysis, investigation, and writing (review/edits). SM: Literature review, investigation, and writing (review/edits). KM: data acquisition, investigation, and writing (review/edits). KM: supervision, intellectual input, writing (review/edits). LDR: supervision, funding acquisition, writing (review/edits). JDW: supervision, intellectual input, writing (review/edits).

Corresponding author

Correspondence to Koji Matsuo.

Ethics declarations

Conflict of interest

Consultant, Clovis Oncology and Tesaro, research funding, Merck (J.D.W.); consultant, Quantgene (L.D.R.); honorarium, Chugai, textbook editorial expense, Springer, and investigator meeting attendance expense, VBL therapeutics (K.M.); advisory board, Tesaro, GSK (M.K.); research funding, MSD (S.M.); none for others.

Ethical approval

This article used publicly available deidentified data and does not contain any studies with human participants performed by any of the authors.

Informed consent

Not applicable for this study (Ethical Committee Exemption, HS-16-00481).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matsuo, K., Klar, M., Mandelbaum, R.S. et al. Minimally invasive interval debulking surgery after neoadjuvant chemotherapy for metastatic ovarian cancer: a national study in the United States. Arch Gynecol Obstet 301, 863–866 (2020). https://doi.org/10.1007/s00404-020-05442-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-020-05442-4

Keywords

Search

Navigation